Wednesday, June 10, 2009

Prize4Life News Digest - 6/10


Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research
Our press release about the ALS Forum ( Check it out and share it with everyone you know!

Researchers plan trial for Lou Gehrig's disease therapy
Q Therapeutics, who have been featured in this digest before, have received a $5M grant from NIH to study a potential ALS therapy using stem cells.


World First: Chinese Scientists Create Pluripotent Stem Cells From Pigs
Scientists have been able to create induced pluripotent stem cells from pigs – a significant achievement that could have major implications for how stem cell research is conducted. These animals could be used to create genetic models for human diseases and grow organs for potential transplants in humans, among other things.

Wednesday, June 3, 2009

Prize4Life News Digest - 6/3


Glowing monkeys 'to aid research'
Researchers in Japan have developed transgenic marmosets that create green fluorescent protein, causing them to glow under UV light. Most significantly, these transgenic animals pass this trait on to their offspring. This could be a valuable way to look at diseases such as Huntington’s, Alzheimer’s, and ALS.


New CEO: Gates Foundation learns from experiments
The Gates Foundation’s new CEO Jeff Raikes says that foundations like theirs have the money and capacity to take some risks in what they choose to invest in – and ideas or projects that fail serve as learning experiences for them. He says that nonprofit organizations must often take the lead in social innovation because neither the private sector nor the government can truly take the same kinds of risks.


KineMed Enters Into Collaboration With Bristol-Myers Squibb
KineMed has announced a two-year collaboration with Bristol-Myers Squibb to focus on Alzheimer’s disease and other neurodegenerative diseases. KineMed was a winner of one of Prize4Life’s Thought Prizes in the ALS Biomarker Challenge. They subsequently received funding from the Michael J. Fox Foundation to apply their work to Parkinson’s disease.